The Prostate Cancer Foundation and Bayer announce Bayer – PCF Darolutamide Challenge Awards
In 2022, darolutamide was FDA-approved in combination with docetaxel chemotherapy for adults with metastatic hormone-sensitive prostate cancer
In 2022, darolutamide was FDA-approved in combination with docetaxel chemotherapy for adults with metastatic hormone-sensitive prostate cancer
India is following a holistic and inclusive approach in alignment with the vison of Universal Health Coverage and the resolute commitment to ‘leave no one behind
Three block copolymers added to RESOMER portfolio of bioabsorbable polymers
‘Sanjeevani’ aims to raise awareness and encourage conversations around the silent cancer epidemic
The campaign for the digital film is being amplified across various digital media platforms such as YouTube, Facebook, Instagram, Twitter, and LinkedIn
The complexity of operating on a one-year-old are many with the organs being tiny, fragile
Approval is for use in myelofibrosis patients with anaemia regardless of prior myelofibrosis therapy
Public private partnership (PPP) with integrated strategy essential to achieve ‘TB Mukt Bharat’ by 2025
To implement AI-enabled chest X-ray solution for TB & COVID-19 screening in Maharashtra through Unitaid funding
Subscribe To Our Newsletter & Stay Updated